Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness케모카인, 가용성 PD-L1 및 면역 세포 저반응은 SARS-CoV-2 중병의 뚜렷한 특징입니다Article Published on 2022-07-012022-09-12 Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome ARDS C-reactive protein CCL17 CCL26 cellular checkpoint pathway chemoattractant comparison coronavirus disease Coronavirus-2 COVID-19 Critical Critically ill patient CRP CXCL10 demographics enrolled feature hyporesponsiveness identify IFN-γ IL-10 IL-17A IL-6 IL-8 immune Immune cell immune signature in vitro Interaction less lymphocyte Migration molecular monocyte mortality rate multisite not significantly different p value Patient patients patients without COVID-19 PD-L1 plasma Pneumonia profile prospective cohort Regulatory SARS-CoV-2 SARS-CoV-2-positive patient SARS-CoV-2-positive patients Sepsis severe respiratory failure severity subject subjects T cell T-cell TNF-α two groups ventilator-free day with COVID-19 [DOI] 10.1152/ajplung.00049.2022 PMC 바로가기 [Article Type] Article
Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection지속적인 항인지질 항체는 SARS-CoV-2 감염으로 입원한 환자의 예상 코호트에서 더 나쁜 임상 결과와 관련이 없습니다Article Published on 2022-06-222022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Admission admitted to ICU age analysed antibody antiphospholipid antibodies antiphospholipid syndrome - immunology association Barcelona clinical Clinical outcome clinical outcomes Cohort conducted COVID COVID - 19 COVID-19 patients criteria Diagnosis elevated hospitalisation hospitalised COVID-19 patient hospitalised patient ICU ICU admission IgG immunology intensive care men outcome Patient patients persistence persistent positive positive result Prevalence prevalent Prospective Prospective Study SARS-CoV-2 separated severe respiratory failure suffered syndrome tested thrombosis thrombosis - immunology. ventilatory with COVID-19 [DOI] 10.3389/fimmu.2022.911979 PMC 바로가기 [Article Type] Article
Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study토실리주맙 치료를 받은 Sars-CoV-2 관련 중증 호흡 부전 환자의 나쁜 결과 예측자: 다기관 실제 세계 연구Multicenter Study Published on 2022-06-012022-09-12 Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 진단, [키워드] Admission admitted to ICU age Analysis analyzed C-reactive protein (CRP CCT chest computer tomography composite endpoint COVID-19 creatinine death died Evidence Factor females Ground glass opacity Hospital admission ICU ICU admission IL-6 antagonist IMPROVE in-hospital mortality independent independent risk factor intensive care unit interleukin-6 intubation Laboratory lack lymphocyte material Mortality multicentre occurred Older outcome oxygen saturation P/F PaO2/FiO2 ratio Patient Pneumonia predictor procalcitonin Prognosis required respiratory Respiratory failure SARS-CoV-2 severe COVID-19 patients severe respiratory failure severe SARS-CoV-2 shown significantly significantly higher study population therapeutic option Tocilizumab tomography treated treated patient Univariate analysis [DOI] 10.1016/j.intimp.2022.108709 PMC 바로가기 [Article Type] Multicenter Study
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure중증 호흡부전이 있는 COVID-19 환자의 구조 치료로서 흡입형 DNase, 바리시티닙 및 토실리주맙의 병용 투여Article Published on 2022-05-012022-09-12 Journal: Clinical immunology (Orlando, Fla.) [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커, 임상, 진단, 치료법, [키워드] Administered administration analysed Baricitinib clinical observations Combined COVID-19 COVID-19 patient dissolve DNase duration of hospitalization fibroblasts Follow-up group hyperinflammation IL-1-receptor Immunomodulatory agent immunothrombosis in-hospital mortality Inhaled inhibited inhibitor intubation rate lung median monotherapy Neutrophil extracellular traps paO2/fiO2 pathway plasma randomized trial reduce mortality severe respiratory failure significantly Standard-of-care Support survival tissue Tissue Factor Tocilizumab Treatment [DOI] 10.1016/j.clim.2022.109016 PMC 바로가기 [Article Type] Article
Lung Transplant as a Treatment for Patients with End-Stage Respiratory Failure Due to COVID-19Research article Published on 2022-05-012022-10-05 Journal: Transplantation proceedings [Category] 치료법, [키워드] acute respiratory distress Analysis contraindications COVID-19 criteria critical condition died discharged donors extracorporeal membrane oxygenation failure feasibility high mortality high-flow oxygen therapy Infection invasive ventilation lack lung lung transplant Mortality Patient patients performed Poland recipients respiratory Respiratory failure Result Retrospective study severe respiratory failure significantly syndrome therapeutic options Transplant Treatment viral disease ward [DOI] 10.1016/j.transproceed.2022.03.017 [Article Type] Research article
Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients기준선에서 가용성 IL-2R 수준은 COVID-19 환자에서 심각한 호흡 부전 및 사망의 발병을 예측합니다Article Published on 2022-04-102022-09-11 Journal: Viruses [Category] 바이오마커, [키워드] 95%CI Admission Algorithm Anakinra Biomarker change clinical outcomes coronavirus coronavirus disease Coronavirus disease-19 Corticosteroid Corticosteroids COVID-19 Critical cut-off Delta development died discharge disease severity Endpoint failure Follow-up hazard ratio Immunoglobulin Immunotherapy interquartile range Intravenous immunoglobulin Intubated intubation Laboratory Level Local local treatment marker median age moderate disease Mortality on admission Patient positive predict Predictive Predictive value receptor respiratory Respiratory failure risk Risk factors risk stratification severe disease severe respiratory failure significantly higher soluble interleukin-2 receptor SRF Stratification the strongest Tocilizumab Treatment were measured [DOI] 10.3390/v14040787 PMC 바로가기 [Article Type] Article
Operation of a triage committee for advanced life support during the COVID-19 pandemicObservational Study Published on 2022-03-162022-10-05 Journal: Philosophy, Ethics, and Humanities in Medicine : P [Category] 임상, [키워드] ADP affected age ALS candidate Clinical characteristics clinical criteria Comorbidity COVID-19 COVID-19 pandemic decision Decision-making determine effective Ethics Ethics Committees/Consultation evaluated First wave foundation functional Health help implementation include involved less male measure median Older operation Other participated Patient patients evaluated physician Public receive resources SARS CoV-2 severe respiratory failure Spain Support the patient Triage university [DOI] 10.1186/s13010-022-00117-1 PMC 바로가기 [Article Type] Observational Study
Detection of anti-Histoplasma capsulatum antibodies and seroconversion patterns in critically ill patients with COVID-19: An underdiagnosed fungal entity complicating COVID-19?COVID-19에 감염된 중환자에서 항히스토플라스마 캡슐화 항체 및 혈청전환 패턴의 검출: COVID-19를 복잡하게 만드는 과소 진단된 곰팡이 개체?Article Published on 2022-03-042022-09-11 Journal: Medical mycology [Category] MERS, SARS, 진단, 치료기술, [키워드] AIDS analyzed antibody Antibody titer Antibody titers Awareness baseline Bearing Buenos Aire Buenos Aires candidiasis classical clinician Co-infection COVID-19 pneumonia COVID-19-associated mycoses Critically ill Critically ill patient critically ill patients death detection Diagnosis died Endemic endemic area endemicity evaluated FIVE fungal fungal disease fungal infections fungus help Histoplasma Histoplasma capsulatum Histoplasmosis HIV/AIDS Hospitalized house ICU IgG antibodies IgG antibody in-house ELISA increased risk infections invasive Invasive pulmonary aspergillosis mind morbidity morbidity and mortality Mycoses Patient positive Prevent pulmonary aspergillosis reduce respiratory Respiratory failure Respiratory function risk risk factor SARS-CoV-2 Sepsis sera Seroconversion seronegative seropositive serum sample serum samples severe COVID-19 Severe COVID-19 pneumonia severe respiratory failure specific IgG antibodies Treatment with COVID-19 worsening [DOI] 10.1093/mmy/myac012 PMC 바로가기 [Article Type] Article
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort studyArticle Published on 2022-03-032023-06-16 Journal: Intensive care medicine [Category] Fulltext, MERS, [키워드] ARDS COVID-19 ECMO severe respiratory failure [DOI] 10.1007/s00134-022-06645-w PMC 바로가기
A Successful Outcome of Veno-Venous Extracorporeal Membrane Oxygenation in Obese Patients with Respiratory Failure in the Course of COVID-19: A Report of Two CasesCase Report Published on 2022-02-272022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] acute respiratory distress ARDS BMI condition Course COVID-19 discharged ECMO ECMO therapy Efficacy Extracorporeal extracorporeal membrane oxygenation failure high mortality implementation indicate intensive care life obese patient obese patients organization outcome PaO Patient patients persistence Pneumonia positive Rapid report respiratory Respiratory failure SARS-CoV-2 SARS-COV-2 infection severe respiratory failure syndrome use of ECMO were used with COVID-19 [DOI] 10.3390/ijerph19052761 PMC 바로가기 [Article Type] Case Report